Furthermore, the median values of AFP in the antiviral group were significantly lower compared to the non-antiviral group in each of HBeAg, HBV DNA, ALT, and AST subgroups for non-HCC patients (Supplementary Figure S2). This evidence concerns the gene AFP and hepatocellular carcinoma.